Journal article

Plasma acetate, gluconate and interleukin-6 profiles during and after cardiopulmonary bypass: A comparison of Plasma-Lyte 148 with a bicarbonate-balanced solution

PG Davies, B Venkatesh, TJ Morgan, JJ Presneill, PS Kruger, BJ Thomas, MS Roberts, J Mundy

Critical Care | BIOMED CENTRAL LTD | Published : 2011

Abstract

Introduction: As even small concentrations of acetate in the plasma result in pro-inflammatory and cardiotoxic effects, it has been removed from renal replacement fluids. However, Plasma-Lyte 148 (Plasma-Lyte), an electrolyte replacement solution containing acetate plus gluconate is a common circuit prime for cardio-pulmonary bypass (CPB). No published data exist on the peak plasma acetate and gluconate concentrations resulting from the use of Plasma-Lyte 148 during CPB.Methods: Thirty adult patients were systematically allocated 1:1 to CPB prime with either bicarbonate-balanced fluid (24 mmol/L bicarbonate) or Plasma-Lyte 148. Arterial blood acetate, gluconate and interleukin-6 (IL-6) level..

View full abstract

University of Melbourne Researchers